Live Breaking News & Updates on Contour System

Stay updated with breaking news from Contour system. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™


Cerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™
News provided by
Share this article
Share this article
FREMONT, Calif. and OXFORD, United Kingdom, Feb. 11, 2021 /PRNewswire/ Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Contour Neurovascular System™.
Breakthrough Device Designation is granted to medical devices and device-led combination products that provide the potential for a more effective treatment option for life-threatening or irreversibly debilitating diseases. The designation expedites the traditional development, assessment and review process, and enables medical professionals to get access to new developments quickly. ....

United Kingdom , Sam Milstein , Stephen Griffin , Lori Adels , Cerus Endovascular , Prnewswire Cerus Endovascular Ltd , Cerus Endovascular Ltd , Drug Administration , Rx Communications Group , Endovascular Ltd , Breakthrough Device Designation , Contour Neurovascular System , Device Designation , Chief Compliance Officer , Investigational Device Exemption , Ceru Chairman , Contour System , Neqstent Coil Assisted Flow Diverter , Communications Group , ஒன்றுபட்டது கிஂக்டம் , சாம் மில்ஸ்டீன் , ஸ்டீபன் கிரிஃபின் , ர்க்ஸ் தகவல்தொடர்புகள் குழு , எண்டோவாஸ்குலர் லிமிடெட் , திருப்புமுனை சாதனம் பதவி , சாதனம் பதவி ,